Dr Dionysis Papadatos-Pastos
Consultant Medical Oncologist
MD MRCP (UK) PhD
Languages spoken: English Greek
Dr Dionysis Papadatos-Pastos
Consultant Medical Oncologist
MD MRCP (UK) PhD
Languages spoken: English Greek
Appointments available at:
Cromwell HospitalPatient Age Group
AdultsYear qualified
2002Specialties
Medical oncology, Lung, Thymus, MesotheliomaGender
MaleClinical Interests
Treatment of lung cancer, thymus cancer, and mesothelioma; immunotherapy; chemotherapy; targeted therapies; and early-stage clinical trials.
About Dr Dionysis Papadatos-Pastos
Dr Dionysis Papadatos-Pastos is a consultant medical oncologist in London. He is the lead for lung cancer in the CRUK UCL Clinical Trials Centre and the joint lead for oncology at The Princess Alexandra NHS Hospital.
He specialises in the treatment of lung cancer, mesothelioma, and thymoma (thymus cancer). Throughout his career, he has gained extensive experience in cancer management using treatments such as immunotherapy, targeted therapies, and chemotherapy.
He graduated in medicine from the University of Athens with distinction, which was followed by his PhD in medical oncology in 2012 with First Class honours. He trained in medical oncology at The Royal Marsden, St George’s University Hospitals, and Guy’s and St Thomas’. He was awarded a diploma in medical oncology from the Institute of Cancer Research at the University of London.
Dr Papadatos-Pastos is an avid researcher and has been the principal investigator on multiple academic and commercial clinical trials. He has also presented at conferences, nationally and worldwide. His topics of research include the development of novel targeted therapies for the treatment of lung cancer, and assessing combinations of immunotherapy drugs with other anti-cancer compounds. Furthermore, he has been widely published in scientific medical journals and peer-reviewed papers.
He specialises in the treatment of lung cancer, mesothelioma, and thymoma (thymus cancer). Throughout his career, he has gained extensive experience in cancer management using treatments such as immunotherapy, targeted therapies, and chemotherapy.
He graduated in medicine from the University of Athens with distinction, which was followed by his PhD in medical oncology in 2012 with First Class honours. He trained in medical oncology at The Royal Marsden, St George’s University Hospitals, and Guy’s and St Thomas’. He was awarded a diploma in medical oncology from the Institute of Cancer Research at the University of London.
Dr Papadatos-Pastos is an avid researcher and has been the principal investigator on multiple academic and commercial clinical trials. He has also presented at conferences, nationally and worldwide. His topics of research include the development of novel targeted therapies for the treatment of lung cancer, and assessing combinations of immunotherapy drugs with other anti-cancer compounds. Furthermore, he has been widely published in scientific medical journals and peer-reviewed papers.
NHS Base (trust)
University College London Hospitals NHS Foundation Trust, The Princess Alexandra Hospital NHS Trust
